NovaTears® Eye Drops Observational Study NT-002
NCT02356341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72
Last updated 2016-03-09
Summary
This observational study is intended to collect outcome data from a cohort of 90 patients suffering from symptoms of dry eye disease due to meibomian gland dysfunction who are treated with the medical device NovaTears® eye drops for a duration of 6 to 8 weeks.
Conditions
- Dry Eye Syndromes
Interventions
- DEVICE
-
NovaTears® Eye Drops
Topical eye drops for lubrication of the ocular surface
Sponsors & Collaborators
-
Novaliq GmbH
lead INDUSTRY
Principal Investigators
-
Novaliq GmbH · Novaliq GmbH
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- Germany
Study Locations
More Related Trials
-
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
NCT00739349 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
NCT02470429 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
NCT01382810 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
NCT05661851 ·Status: COMPLETED ·Phase: PHASE2
-
Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients
NCT05304637 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease
NCT01753596 ·Status: WITHDRAWN ·Phase: PHASE3
-
iTear Single-center, Open-label, Single-arm Study
NCT06525961 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
NCT02365519 ·Status: COMPLETED ·Phase: PHASE2
-
Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease
NCT05857748 ·Status: WITHDRAWN
-
Tear Dynamics After Restasis Treatment in Dry Eye Patients
NCT00706940 ·Status: COMPLETED
-
Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT03211351 ·Status: COMPLETED ·Phase: NA
-
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134 ·Status: TERMINATED ·Phase: PHASE4
-
Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes
NCT01363414 ·Status: COMPLETED ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome
NCT00814515 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye
NCT06537349 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
NCT07025811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
PMCF Study to Evaluate Performance and Safety of "Ocular Drops Based Upon Carmellose" Used to Relieve Dry Eye Symptoms
NCT05825352 ·Status: COMPLETED ·Phase: NA
-
Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
NCT02121847 ·Status: COMPLETED ·Phase: PHASE4
-
Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
NCT05505292 ·Status: COMPLETED ·Phase: PHASE4